Management of immediate and sustained intraocular pressure rise associated with intravitreal antivascular endothelial growth factor injection therapy. [electronic resource]
Producer: 20130327Description: 105-10 p. digitalISSN:- 1531-7021
- Angiogenesis Inhibitors -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antihypertensive Agents -- therapeutic use
- Bevacizumab
- Decompression, Surgical
- Humans
- Intraocular Pressure
- Intravitreal Injections
- Ocular Hypertension -- chemically induced
- Tonometry, Ocular
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.